P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(0.27) per share. The company reported quarterly sales of $248.26 million which beat the analyst consensus estimate of $178.84 million by 38.82 percent. This is a 58.95 percent increase over sales of $156.19 million the same period last year.
Reported December 29, 2023, Aditxt Announced A $6M Private Placement Of 1,237,114 Shares Of Common Stock At A Price Of $4.85/Share And Accompanying Warrant, Priced At-The-Market Under Nasdaq Rules
Aditxt, Inc., (NASDAQ:ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered
